Relación precio/utilidad neta (P/E)
desde 2005
Cálculo
Danaher Corp., P/E, tendencias a largo plazocálculo
| P/E | = | Precio de la acción1, 2, 3 | ÷ | Beneficio por acción1 (EPS) | EPS1 | = | Utilidad neta atribuible a los accionistas ordinarios1 (en millones) | ÷ | Número de acciones ordinarias en circulación2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20 feb 2025 | 38.12 | = | 207.95 | ÷ | 5.46 | 5.46 | = | 3,899 | ÷ | 714,709,852 | |
| 21 feb 2024 | 39.09 | = | 250.65 | ÷ | 6.41 | 6.41 | = | 4,743 | ÷ | 739,701,725 | |
| 22 feb 2023 | 25.65 | = | 250.11 | ÷ | 9.75 | 9.75 | = | 7,103 | ÷ | 728,576,886 | |
| 23 feb 2022 | 29.94 | = | 262.39 | ÷ | 8.76 | 8.76 | = | 6,269 | ÷ | 715,352,586 | |
| 25 feb 2021 | 44.49 | = | 219.26 | ÷ | 4.93 | 4.93 | = | 3,510 | ÷ | 712,204,198 | |
| 21 feb 2020 | 38.34 | = | 161.88 | ÷ | 4.22 | 4.22 | = | 2,940 | ÷ | 696,237,113 | |
| 21 feb 2019 | 29.77 | = | 112.43 | ÷ | 3.78 | 3.78 | = | 2,651 | ÷ | 701,875,340 | |
| 21 feb 2018 | 27.25 | = | 97.35 | ÷ | 3.57 | 3.57 | = | 2,492 | ÷ | 697,569,470 | |
| 22 feb 2017 | 23.02 | = | 84.80 | ÷ | 3.68 | 3.68 | = | 2,554 | ÷ | 693,280,277 | |
| 24 feb 2016 | 17.85 | = | 87.20 | ÷ | 4.89 | 4.89 | = | 3,357 | ÷ | 687,154,521 | |
| 25 feb 2015 | 23.69 | = | 87.22 | ÷ | 3.68 | 3.68 | = | 2,598 | ÷ | 705,777,722 | |
| 21 feb 2014 | 19.74 | = | 76.15 | ÷ | 3.86 | 3.86 | = | 2,695 | ÷ | 698,482,191 | |
| 22 feb 2013 | 17.73 | = | 61.46 | ÷ | 3.47 | 3.47 | = | 2,392 | ÷ | 690,246,149 | |
| 24 feb 2012 | 16.92 | = | 53.32 | ÷ | 3.15 | 3.15 | = | 2,172 | ÷ | 689,294,694 | |
| 24 feb 2011 | 18.29 | = | 49.76 | ÷ | 2.72 | 2.72 | = | 1,793 | ÷ | 659,181,326 | |
| 24 feb 2010 | 20.93 | = | 37.26 | ÷ | 1.78 | 1.78 | = | 1,152 | ÷ | 646,964,568 | |
| 25 feb 2009 | 12.56 | = | 25.97 | ÷ | 2.07 | 2.07 | = | 1,318 | ÷ | 637,402,212 | |
| 21 feb 2008 | 17.35 | = | 37.33 | ÷ | 2.15 | 2.15 | = | 1,370 | ÷ | 636,600,000 | |
| 1 mar 2007 | 19.65 | = | 35.66 | ÷ | 1.81 | 1.81 | = | 1,122 | ÷ | 618,200,000 | |
| 15 mar 2006 | 21.38 | = | 31.40 | ÷ | 1.47 | 1.47 | = | 898 | ÷ | 611,200,000 |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
1 US$
2 Datos ajustados por divisiones y dividendos de acciones.
3 Precio de cierre a la fecha de presentación del informe anual de Danaher Corp.
Comparación con la competencia
Danaher Corp., P/E, tendencias a largo plazo, comparación con los competidores
| Danaher Corp. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20 feb 2025 | 38.12 | 79.59 | 38.24 | — | 77.63 | 296.57 | 26.92 | 13.49 | 18.42 | 17.76 | 32.03 | — |
| 21 feb 2024 | 39.09 | 63.84 | 23.14 | 12.27 | 135.24 | 16.17 | 10.73 | 893.99 | 73.42 | 25.99 | 35.65 | 30.42 |
| 22 feb 2023 | 25.65 | 22.62 | 19.56 | 23.97 | 50.08 | 22.68 | 22.97 | 19.21 | 7.58 | 19.68 | 30.55 | 23.02 |
| 23 feb 2022 | 29.94 | 22.07 | 21.05 | 20.92 | 40.66 | 12.36 | 20.93 | 14.78 | 11.76 | 8.37 | 27.35 | 26.55 |
| 25 feb 2021 | 44.49 | 40.17 | 18.82 | — | 31.95 | 641.48 | 28.92 | 26.72 | 19.62 | 15.09 | 27.89 | 20.18 |
| 21 feb 2020 | 38.34 | 17.82 | 17.07 | 41.99 | 16.19 | 16.45 | 25.99 | 20.60 | 11.63 | 19.86 | 33.36 | 52.90 |
| 21 feb 2019 | 29.77 | 20.60 | 14.01 | 16.81 | 39.13 | 15.26 | 23.74 | 33.46 | 21.58 | 18.17 | 35.19 | 22.59 |
| 21 feb 2018 | 27.25 | 35.47 | 64.06 | 103.55 | — | 22.75 | 268.10 | 61.63 | 9.99 | 28.99 | 37.66 | 155.08 |
| 22 feb 2017 | 23.02 | 16.54 | 16.03 | 20.56 | 32.39 | 6.83 | 20.08 | 46.14 | 28.10 | 42.64 | 30.45 | — |
| 24 feb 2016 | 17.85 | 17.01 | 15.95 | 64.22 | 33.35 | 6.75 | 18.80 | 31.64 | 26.37 | 60.50 | 26.19 | — |
| 25 feb 2015 | 23.69 | 55.08 | 22.96 | 49.80 | 33.06 | 12.85 | 17.15 | 13.94 | 23.03 | 118.44 | 27.26 | — |
| 21 feb 2014 | 19.74 | 19.64 | 18.69 | 35.01 | 13.88 | 42.00 | 18.72 | 37.83 | 9.32 | 77.00 | 38.43 | — |
| 22 feb 2013 | 17.73 | 11.51 | 15.68 | 30.56 | 14.99 | 25.20 | 19.64 | 20.94 | 13.51 | 21.42 | 22.54 | — |
| 24 feb 2012 | 16.92 | — | 14.61 | 15.07 | 10.42 | 12.20 | 18.48 | 18.63 | 15.99 | — | 15.58 | 267.42 |
| 24 feb 2011 | 18.29 | — | 10.53 | 13.99 | 7.86 | 10.68 | 12.23 | 116.63 | 18.63 | — | 20.87 | — |
| 24 feb 2010 | 20.93 | — | 12.10 | 4.03 | 9.18 | 16.29 | 14.22 | 9.00 | 16.41 | — | 23.49 | — |
| 25 feb 2009 | 12.56 | — | 12.06 | 7.68 | — | 20.29 | 11.67 | 6.53 | 10.25 | — | 15.25 | — |
| 21 feb 2008 | 17.35 | — | 15.64 | 20.60 | 19.26 | 25.19 | 17.07 | 29.88 | 18.51 | — | 30.76 | — |
| 1 mar 2007 | 19.65 | — | 25.43 | 34.64 | 22.40 | — | 17.02 | 21.57 | 9.18 | — | 113.28 | — |
| 15 mar 2006 | 21.38 | — | 23.70 | 14.96 | 31.90 | 34.15 | 16.95 | 16.62 | 23.92 | — | 25.36 | — |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
Comparativa con el sector industrial: Pharmaceuticals, Biotechnology & Life Sciences
Danaher Corp., P/E, tendencias a largo plazo, en comparación con el sector industrial: pharmaceuticals, biotechnology & life sciences
| Danaher Corp. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| 20 feb 2025 | 38.12 | 45.15 |
| 21 feb 2024 | 39.09 | 32.80 |
| 22 feb 2023 | 25.65 | 20.23 |
| 23 feb 2022 | 29.94 | 19.27 |
| 25 feb 2021 | 44.49 | 34.89 |
| 21 feb 2020 | 38.34 | 21.03 |
| 21 feb 2019 | 29.77 | 22.89 |
| 21 feb 2018 | 27.25 | 35.21 |
| 22 feb 2017 | 23.02 | 20.62 |
| 24 feb 2016 | 17.85 | 19.37 |
| 25 feb 2015 | 23.69 | 21.40 |
| 21 feb 2014 | 19.74 | 19.54 |
| 22 feb 2013 | 17.73 | 17.56 |
| 24 feb 2012 | 16.92 | 16.42 |
| 24 feb 2011 | 18.29 | 16.11 |
| 24 feb 2010 | 20.93 | 11.66 |
| 25 feb 2009 | 12.56 | 12.21 |
| 21 feb 2008 | 17.35 | 20.04 |
| 1 mar 2007 | 19.65 | 17.46 |
| 15 mar 2006 | 21.38 | 20.94 |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
Comparación con la industria: Health Care
Danaher Corp., P/E, tendencias a largo plazo, en comparación con la industria: health care
| Danaher Corp. | Health Care | |
|---|---|---|
| 20 feb 2025 | 38.12 | 37.14 |
| 21 feb 2024 | 39.09 | 29.43 |
| 22 feb 2023 | 25.65 | 342,408.13 |
| 23 feb 2022 | 29.94 | 21.35 |
| 25 feb 2021 | 44.49 | 30.75 |
| 21 feb 2020 | 38.34 | 21.64 |
| 21 feb 2019 | 29.77 | 25.29 |
| 21 feb 2018 | 27.25 | 30.93 |
| 22 feb 2017 | 23.02 | 21.47 |
| 24 feb 2016 | 17.85 | 19.50 |
| 25 feb 2015 | 23.69 | 21.56 |
| 21 feb 2014 | 19.74 | 18.62 |
| 22 feb 2013 | 17.73 | 15.80 |
| 24 feb 2012 | 16.92 | 15.84 |
| 24 feb 2011 | 18.29 | 15.00 |
| 24 feb 2010 | 20.93 | 11.75 |
| 25 feb 2009 | 12.56 | 12.99 |
| 21 feb 2008 | 17.35 | 19.44 |
| 1 mar 2007 | 19.65 | 18.63 |
| 15 mar 2006 | 21.38 | 21.68 |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).